Literature DB >> 10878365

Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells.

D J Philpott1, S Yamaoka, A Israël, P J Sansonetti.   

Abstract

The pathogenesis of Shigella flexneri infection centers on the ability of this organism to invade epithelial cells and initiate an intense inflammatory reaction. Because NF-kappa B is an important transcriptional regulator of genes involved in inflammation, we investigated the role of this transcription factor during S. flexneri infection of epithelial cells. Infection of HeLa cells with invasive S. flexneri induced NF-kappa B DNA-binding activity; noninvasive S. flexneri strains did not lead to this activation. The pathway leading to NF-kappa B activation by invasive S. flexneri involved the kinases, NF-kappa B-inducing kinase, I kappa B kinase-1, and I kappa B kinase-2. NF-kappa B activation was linked to inflammation, because invasive S. flexneri activated an IL-8 promoter-driven reporter gene, and the kappa B site within this promoter was indispensable for its induction. Microinjection of bacterial culture supernatants into HeLa cells suggested that LPS is responsible for NF-kappa B activation by S. flexneri infection. In conclusion, the eukaryotic transcription factor NF-kappa B was activated during S. flexneri infection of epithelial cells, which suggests a role for this transcriptional regulator in modulating the immune response during infection in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878365     DOI: 10.4049/jimmunol.165.2.903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  NF-kappa B may determine whether epithelial cell--microbial interactions in the intestine are hostile or friendly.

Authors:  Y R Mahida; S Johal
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 3.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

4.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

Review 5.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 6.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon.

Authors:  D Berrebi; R Maudinas; J-P Hugot; M Chamaillard; F Chareyre; P De Lagausie; C Yang; P Desreumaux; M Giovannini; J-P Cézard; H Zouali; D Emilie; M Peuchmaur
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

8.  Innate recognition of bacteria by a macrophage cytosolic surveillance pathway.

Authors:  Mary O'Riordan; Caroline H Yi; Ramona Gonzales; Kyung-Dall Lee; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

Review 9.  CARD games in apoptosis and immunity.

Authors:  Lisa Bouchier-Hayes; Seamus J Martin
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

Review 10.  The immunology of neurodegeneration.

Authors:  Eva Czirr; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.